Navigation Links
StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
Date:10/31/2007

MENLO PARK, Calif., Oct. 31 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing systems for Enabling Regenerative Medicine(TM), announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its MarrowMiner(TM) for the harvest of bone marrow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071030/STEMCORSYSTEMSLOGO)

"Regulatory clearance of StemCor's MarrowMiner is a major accomplishment for the Company as we develop the necessary tools to extract, process and deliver bone marrow-derived adult stem and progenitor cells," said Vartan Ghazarossian, PhD, President and CEO of StemCor Systems. "The MarrowMiner is the first minimally-invasive system for the collection of bone marrow, making marrow extraction faster, safer and more comfortable. Physicians will now be able to use this system to collect marrow from healthy donors for bone marrow transplantation, as well as from patients who are to be treated with their own marrow-derived cells, for an expanding array of current and emerging regenerative medicine applications."

"We believe this novel and innovative system addresses a large unmet clinical need to gain access to sufficient adult-bone marrow derived cells in a safe, convenient and reliable manner," said Paul Yock, MD, Weiland Professor of Medicine and Bioengineering and Director, Program in Biodesign, Stanford University. "This technology meets a key need to access a patient's own cells for use in treating a variety of diseases and conditions."

About the MarrowMiner

The proprietary MarrowMiner system is designed to rapidly and easily harvest bone marrow in a minimally-invasive manner, in the outpatient setting, and without general anesthesia. The system consists of an access guide, a powered handle that drives a flexible atraumatic shaft through which marrow is aspirated, and an integrated marrow collection container. The MarrowMiner shaft gains access to the bone marrow cavity through the access guide to allow the removal of bone marrow through a single entry site. This is in contrast to the current practice of bone marrow aspiration through the insertion of a needle into multiple sites in the iliac crest of the hip, which usually requires general anesthesia, an operating room, and multiple clinical personnel. Preclinical studies demonstrated the ability of the MarrowMiner to safely harvest large volumes of marrow with significantly higher stem cell activity than is contained in standard needle aspirates.

About Bone Marrow

Bone marrow is a rich source of both adult stem and progenitor cells. Marrow-derived stem cells have been utilized extensively for over 40 years in the field of bone marrow transplantation, primarily for the treatment of a wide array of cancers and hematologic diseases for which over 60,000 transplants are performed each year. Orthopedic procedures, such as spinal fusions and the treatment of non-union fractures, also commonly utilize the patient's own bone marrow. More recently, marrow-derived cells are showing promise in the treatment of a widening array of diseases and conditions.

About Regenerative Therapies

Regenerative medicine focuses on the ability to repair or regenerate damaged, diseased or aging tissues, and is rapidly emerging as the next frontier in medicine. Regenerative therapies have the potential to provide effective therapies for millions of patients worldwide suffering from a wide array of diseases, including cardiovascular, neurologic, and orthopedic diseases and diabetes. A critical aspect of many regenerative therapies is the ability to collect the patient's own stem cells, and later process, select and deliver these cells to a target organ.

About StemCor

StemCor Systems is a privately held medical device company located in the San Francisco Bay Area developing enabling technologies for regenerative medicine. The company's initial product is the MarrowMiner, a proprietary, minimally-invasive bone marrow collection system. The technology was invented by Daniel Kraft, MD, and was licensed exclusively from Stanford University. Clinical studies are now underway to evaluate the potential of the bone marrow collection system to obtain sufficient and high quality marrow-derived cells.

Contact: Vartan Ghazarossian, PhD

President and CEO

StemCor Systems, Inc.

650-321-6884

Vartan@StemCorSystems.com


'/>"/>
SOURCE StemCor Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New Computerized Imaging Systems Help In Better Dental Treatment Planning
2. Painkilling Patch As Effective As Intravenous Delivery Systems
3. WHO says damage to eco systems are affecting human health
4. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
5. Ventilation Systems Not Effective in Blocking Tobacco Smoke
6. Poland: Parental warning systems are likely to be adopted in video games.
7. A booster for immune systems: unhygienic environs?
8. Will Baby Jabs Play Truant? NHS Says “No”, Alternate Systems in Plae
9. 3-D Imaging For Monitoring Reactor Systems, Power Plants
10. Global Seagrass Decline Affects Shallow-water Ecosystems
11. Meira Kumar Suggests Monitoring Systems To Check Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: